Nasdaq Ocs News Today

Oculis Holding AG (NASDAQ:OCS – Get Free Report)’s stock price traded up 8.3% during mid-day trading on Monday . The company traded as high as $13.16 and last traded at $13.02. 82,027 shares traded hands during mid-day trading, an increase of 74% from the average session volume of 47,052 shares. The stock had previously closed […]

ZUG, Switzerland and BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company...

Shares of Oculis Holding AG (NASDAQ:OCS – Get Free Report) have been given an average recommendation of “Buy” by the nine research firms that are covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have updated their coverage on […]

Shares of Oculis Holding AG (NASDAQ:OCS – Get Free Report) saw strong trading volume on Thursday . 168,639 shares were traded during mid-day trading, an increase of 227% from the previous session’s volume of 51,628 shares.The stock last traded at $14.00 and had previously closed at $11.93. Wall Street Analyst Weigh In A number of […]

Shares of Oculis Holding AG (NASDAQ:OCS – Get Free Report) have earned an average rating of “Buy” from the nine brokerages that are currently covering the company, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have updated their coverage on the stock […]

Wedbush reiterated their outperform rating on shares of Oculis (NASDAQ:OCS – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $29.00 price objective on the stock. Other equities research analysts have also issued research reports about the stock. Robert W. Baird upped their price objective on shares of Oculis […]

Oculis (NASDAQ:OCS – Free Report) had its price target hoisted by HC Wainwright from $28.00 to $29.00 in a research report sent to investors on Wednesday, FlyOnTheWall reports. Other research analysts also recently issued reports about the company. Robert W. Baird began coverage on Oculis in a report on Wednesday, June 7th. They issued an […]

Robert W. Baird started coverage on shares of Oculis (NASDAQ:OCS – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The brokerage set an “outperform” rating on the stock. A number of other analysts also recently commented on the stock. Pareto Securities assumed coverage on shares of Oculis in a report […]

ZUG, Switzerland and BOSTON, May 31, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company purposefully driven to...

Equities research analysts at Pareto Securities started coverage on shares of Oculis (NASDAQ:OCS – Get Rating) in a research report issued to clients and investors on Wednesday, The Fly reports. The brokerage set a “buy” rating and a $23.00 price target on the stock. Pareto Securities’ price target indicates a potential upside of 119.05% from […]